Campus Digest

SCM webinar draws insights on the global development of Chinese medicine

Monday, 29 August 2022

20220821_SCM_HKAIM Webinar_2_re 20220821_SCM_HKAIM Webinar_2_re
From left: Professor Bian Zhaoxiang, Associate Vice-President (Chinese Medicine Development) of HKBU and Honorary President of HKAIM; Professor Lyu Aiping, Dean of Chinese Medicine at HKBU; Professor Vivian Taam Wong, Honorary President of HKAIM; Professor Lin Zhixiu, Director of the School of Chinese Medicine at The Chinese University of Hong Kong and President of HKAIM; and Professor Zhong Lidan, Assistant Professor of SCM and Vice President of HKAIM, welcome the honourable guests at the opening ceremony.

 

With the aim of providing a platform for international dialogue on the development of Chinese medicine, the School of Chinese Medicine (SCM) co-hosted a webinar entitled “21st Century Chinese Medicine Internationalisation Strategy” with the Hong Kong Association for Integration of Chinese-Western Medicine (HKAIM) on 21 August.  

Officiating at the opening ceremony were Professor Lo Chung-mau, Secretary for Health of the HKSAR Government; Dr Ko Wing-man, Member of the Executive Council of the HKSAR Government and Honorary President of HKAIM; Dr Leong Che-hung, Former Chairman of the Hospital Authority and the Council of The University of Hong Kong; Professor Alexander Wai, President and Vice-Chancellor of HKBU; and Professor Lyu Aiping, Dean of Chinese Medicine at HKBU.

Addressing the participants at the opening ceremony, Professor Lo said 2022 marks a significant milestone for the development of Chinese medicine in Hong Kong, as the construction of two pieces of flagship infrastructure started in the year. They include the city’s first Chinese Medicine Hospital operated by HKBU, and the Government Chinese Medicines Testing Institute managed by the Department of Health. He said these two flagship pieces of infrastructure will take the development of Chinese medicine in Hong Kong to the next level.

In his welcome remarks, Professor Wai said Chinese medicine is being increasingly recognised in Hong Kong in view of the Government’s ongoing efforts to integrate Chinese medicine into the public health system. He believes that the issuance of the Construction Plan for the Chinese Medicine Highlands in the Guangdong–Hong Kong–Macao Greater Bay Area (2020-2025) by the National Administration of Traditional Chinese Medicine will open up even more new opportunities for Chinese medicine and further unleash its potential.  

The event featured distinguished speakers from around the world, including experts in pharmaceutical sciences, integrative medicine and biomedicine as well as university leaders. They shared their valuable insights with over 400 participants at four different panel sessions which addressed the themes of “International Regulations and Policies”, “Research and Development in Hong Kong Universities”, “National 14th Five-Year Plan – Key Performance Indicators” and “Industry and Markets – Perspectives from the Greater Bay Area”.